Datum Orthobiologics
Orthopedic Tissue Regeneration Solutions
Company Overview
Snapshot
Founded in May 2014 by Itay Itzhaky, Datum Orthobiologics operated with 1–10 employees. The company focused on developing innovative orthopedic ossification, bone formation, and tissue regeneration solutions. In February 2019, Datum Orthobiologics ceased operations.
Business overview
Datum Orthobiologics was a Health Tech & Life Sciences company specializing in orthopedic ossification, bone formation, and tissue regeneration. The company developed advanced biomaterials, including products featuring its patented GLYMATRIX technology, designed to improve the long-term healing and regeneration of musculoskeletal components. Datum Orthobiologics focused its initial efforts on bone graft products, targeting applications such as spinal fusion and fracture grafts in trauma medicine.
Strategic signal
Datum Orthobiologics ceased operations in February 2019, indicating a discontinuation of its efforts in orthopedic tissue regeneration. This event signals to investors and innovation teams that the company's biomaterial development and application in musculoskeletal healing did not achieve sustainable commercial viability.
Company Intelligence Q&A
- What was Datum Orthobiologics' primary focus?
- Datum Orthobiologics focused on providing innovative orthopedic ossification, bone formation, and tissue regeneration solutions, developing advanced biomaterials for musculoskeletal healing.
- When was Datum Orthobiologics founded and by whom?
- Datum Orthobiologics was founded in May 2014 by Itay Itzhaky.
- What was the status of Datum Orthobiologics?
- Datum Orthobiologics ceased to operate in February 2019.
- What technology did Datum Orthobiologics utilize?
- Datum Orthobiologics utilized its patented GLYMATRIX technology in its products, which had been used safely and effectively in over half a million dental and aesthetic procedures prior to its application in orthobiologics.
- What markets did Datum Orthobiologics target with its products?
- Datum Orthobiologics focused its initial efforts on bone graft products for applications such as spinal fusion and fracture grafts in trauma medicine.